Descriptor English: Doxorubicin
Descriptor Spanish: Doxorrubicina
Descriptor doxorrubicina
Entry term(s) adriamicina
Scope note: Antibiótico antineoplásico obtenido de Streptomyces peucetius. Es un derivado hidroxilado de la DAUNORRUBICINA.
Descriptor Portuguese: Doxorrubicina
Descriptor French: Doxorubicine
Entry term(s): Adriablastin
DOXO cell
Doxorubicin Hexal
Doxorubicin Hydrochloride
Doxorubicin NC
Doxorubicina Ferrer Farm
Doxorubicina Funk
Doxorubicina Tedec
Doxorubicine Baxter
Hydrochloride, Doxorubicin
Urokit Doxo cell
Urokit Doxo-cell
Tree number(s): D02.455.426.559.847.562.050.200.175
RDF Unique Identifier:
Scope note: Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Number: 80168379AG
CAS Type 1 Name: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Previous Indexing: Antibiotics, Antineoplastic (1967-1972)
Public MeSH Note: 78; see ADRIAMYCIN 1973-77
History Note: 78(73)
DeCS ID: 24023
Unique ID: D004317
NLM Classification: QV 269
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/07/05
Doxorubicin - Preferred
Concept UI M0006784
Scope note Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
Preferred term Doxorubicin
Farmiblastina - Narrower
Concept UI M0479794
Preferred term Farmiblastina
Ribodoxo - Narrower
Concept UI M0479796
Preferred term Ribodoxo
Rubex - Narrower
Concept UI M0479798
Preferred term Rubex
Adriamycin - Narrower
Concept UI M0546535
Preferred term Adriamycin
Adriblastin - Narrower
Concept UI M0546536
Preferred term Adriblastin
Entry term(s) Adriablastin
Adrimedac - Narrower
Concept UI M0479790
Preferred term Adrimedac
DOXO-cell - Narrower
Concept UI M0479792
Preferred term DOXO-cell
Entry term(s) DOXO cell
Urokit Doxo cell
Urokit Doxo-cell
Doxolem - Narrower
Concept UI M0479784
Preferred term Doxolem
Doxorubicin Hexal - Narrower
Concept UI M0479791
Preferred term Doxorubicin Hexal
Doxorubicin Hydrochloride - Narrower
Concept UI M0006787
Preferred term Doxorubicin Hydrochloride
Entry term(s) Hydrochloride, Doxorubicin
Doxorubicin NC - Narrower
Concept UI M0479789
Preferred term Doxorubicin NC
Doxorubicina Ferrer Farm - Narrower
Concept UI M0479788
Preferred term Doxorubicina Ferrer Farm
Doxorubicina Funk - Narrower
Concept UI M0479787
Preferred term Doxorubicina Funk
Doxorubicina Tedec - Narrower
Concept UI M0479786
Preferred term Doxorubicina Tedec
Doxorubicine Baxter - Narrower
Concept UI M0479785
Preferred term Doxorubicine Baxter
Doxotec - Narrower
Concept UI M0479795
Preferred term Doxotec
Myocet - Narrower
Concept UI M0479793
Preferred term Myocet
Onkodox - Narrower
Concept UI M0479797
Preferred term Onkodox

We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey